Oxidized high-density lipoprotein impairs the function of human renal proximal tubule epithelial cells through CD36

Xiang Gao1, Jianxiang Wu2, Yixin Qian1

  • 1Kidney Institute of PLA, Department of Medicine, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.

Insights

Oxidized high-density lipoprotein (HDL) damages kidney cells by increasing inflammation and cell death. This damage is primarily mediated by the scavenger receptor CD36 and associated signaling pathways.

Area of Science:

  • Nephrology
  • Cell Biology
  • Biochemistry

Background:

  • Native high-density lipoprotein (HDL) is protective, but oxidized HDL (oxHDL) has detrimental effects in diseases like chronic kidney disease (CKD).
  • The precise mechanisms by which oxHDL contributes to CKD progression, particularly in renal tubular cells, are not fully understood.

Purpose of the Study:

  • To investigate the effects of oxHDL on human renal proximal tubule epithelial cells (HK-2).
  • To elucidate the role of the scavenger receptor CD36 and key signaling pathways (Src, MAPK, NF-κB) in mediating oxHDL-induced renal cell damage.

Main Methods:

  • Human renal proximal tubule epithelial cells (HK-2) were treated with varying concentrations of oxHDL.
  • CD36 expression was inhibited using small interfering RNA (siRNA) prior to oxHDL stimulation.
  • Cellular responses including reactive oxygen species (ROS) production, pro-inflammatory factor expression, apoptosis, migration, and signaling pathway activation (Src, MAPK, NF-κB) were assessed.

Main Results:

  • Oxidized HDL dose-dependently increased ROS production, pro-inflammatory factor expression, and apoptosis in HK-2 cells.
  • Oxidized HDL reduced the migration ability of HK-2 cells in a dose-dependent manner.
  • Activation of Src family kinase, MAPK, and NF-κB pathways was observed following oxHDL stimulation.
  • CD36 siRNA significantly attenuated all the adverse effects induced by oxHDL on HK-2 cells.

Conclusions:

  • Oxidized HDL promotes inflammation and impairs the function of renal tubular cells.
  • The scavenger receptor CD36 plays a critical role in mediating the detrimental effects of oxHDL on kidney cells.
  • The Src, MAPK, and NF-κB signaling pathways are key mediators of oxHDL-induced renal cell injury.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
586
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
4.6K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.2K
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
1.2K
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
28
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.4K